These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1637967)

  • 21. Exact permutational tests for group sequential clinical trials.
    Mehta CR; Patel N; Senchaudhuri P; Tsiatis A
    Biometrics; 1994 Dec; 50(4):1042-53. PubMed ID: 7786986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous and group sequential conditional probability ratio tests for phase II clinical trials.
    Tan M; Xiong X
    Stat Med; 1996 Oct; 15(19):2037-51. PubMed ID: 8896138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interim analysis in therapeutic trials: a brief survey of current developments].
    Falissard B; Lellouch J
    Rev Epidemiol Sante Publique; 1991; 39(4):365-72. PubMed ID: 1754702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential monitoring for comparison of changes in a response variable in clinical studies.
    Wu MC; Lan KK
    Biometrics; 1992 Sep; 48(3):765-79. PubMed ID: 1420840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.
    Geller NL; Pocock SJ
    Biometrics; 1987 Mar; 43(1):213-23. PubMed ID: 3567306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A group sequential procedure for all-pairwise comparisons of k treatments based on the range statistic.
    Liu W
    Biometrics; 1995 Sep; 51(3):946-55. PubMed ID: 7548710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the design and analysis of randomized clinical trials with multiple endpoints.
    Tang DI; Geller NL; Pocock SJ
    Biometrics; 1993 Mar; 49(1):23-30. PubMed ID: 8513104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sequential analysis of repeated binary responses: a score test for the case of three time points.
    Sooriyarachchi MR; Whitehead J; Whitehead A; Bolland K
    Stat Med; 2006 Jul; 25(13):2196-214. PubMed ID: 16220479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A group-sequential design for clinical trials with treatment selection.
    Stallard N; Friede T
    Stat Med; 2008 Dec; 27(29):6209-27. PubMed ID: 18792085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size re-estimation in group-sequential response-adaptive clinical trials.
    Morgan CC
    Stat Med; 2003 Dec; 22(24):3843-57. PubMed ID: 14673942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Problems raised by interim analysis in therapeutic trials].
    Rodary C; Nougue CC
    Bull Cancer; 1982; 69(4):387-92. PubMed ID: 7150794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing.
    Tan M; Xiong X; Kutner MH
    Biometrics; 1998 Jun; 54(2):682-95. PubMed ID: 9629648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment allocation for nonlinear models in clinical trials: the logistic model.
    Begg CB; Kalish LA
    Biometrics; 1984 Jun; 40(2):409-20. PubMed ID: 6487725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Design and analysis of phase II trials in oncology with a group sequential method, the triangular test].
    Bellissant E; Bénichou J; Chastang C
    Therapie; 1991; 46(1):21-7. PubMed ID: 2020920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group sequential methods for comparison of cure rates in clinical trials.
    Lee JW; Sather HN
    Biometrics; 1995 Jun; 51(2):756-63. PubMed ID: 7662857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring pairwise comparisons in multi-armed clinical trials.
    Follmann DA; Proschan MA; Geller NL
    Biometrics; 1994 Jun; 50(2):325-36. PubMed ID: 8068834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.